喜讯：新型冠状病毒疫苗启动临床试验
Good News-the Novel Coronavirus Vaccine Starts Clinical Trials
汉英双语作者｜周柯楠
* * * * *
由军事医学研究院陈薇院士领衔的科研团队自抵达武汉以来，就集中力量研制新型冠状病毒疫苗。
Since its arrival in Wuhan, the scientific research team led by Academician Chen Wei of the Military Medical Research Institute has concentrated its efforts on the development of novel coronavirus vaccine.
3月16日陈薇院士团队研制的重组新型冠状病毒疫苗获批启动临床试验。
On March 16th, the recombinant novel coronavirus vaccine developed by Academician Chen Wei’s team was approved to start clinical trials.
陈薇院士团队联合地方优势企业，在埃博拉疫苗成功研发的经验基础上，开展重组新型冠状病毒疫苗的研究，快速完成了新冠疫苗设计、重组毒种构建以及疫苗安全性、有效性评价和质量复核。
Academician Chen Wei’s team, together with local superior enterprises, has carried out the research on the recombinant novel coronavirus vaccine on the basis of the experience of the successful development of the Ebola vaccine, and quickly completed the design of the novel coronavirus vaccine, the construction of the recombinant virus seed as well as the safety, effectiveness evaluation and quality review of the vaccine.
3月16日晚上，陈薇院士团队研制的新型冠状病毒疫苗通过了临床研究注册审评，获批进入临床试验。
On the evening of March 16th, the novel coronavirus vaccine developed by Academician Chen Wei’s team passed the clinical research registration review and was approved to enter the clinical trials.
中国工程院院士陈薇在接受央视记者独家采访时介绍，按照国际规范和国内法规，疫苗已经做到了安全、有效、质量可控，大规模生产的前期准备工作也已经完成。
Chen Wei, academician of the Chinese Academy of Engineering, said in an exclusive interview with a CCTV reporter that in accordance with international norms and domestic regulations, the vaccine has been made safe, effective, and of controllable quality. The preparatory work for mass production of the vaccine has been completed.
閱讀更多 周柯楠 的文章
